BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2024 3:11:19 PM | Browse: 283 | Download: 993
Publication Name World Journal of Diabetes
Manuscript ID 94745
Country Kuwait
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biochemical Research Methods
Manuscript Type Editorial
Article Title MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease
Manuscript Source Invited Manuscript
All Author List Ashraf Al Madhoun
ORCID
Author(s) ORCID Number
Ashraf Al Madhoun http://orcid.org/0000-0001-8593-3878
Funding Agency and Grant Number
Funding Agency Grant Number
Kuwait Foundation for the Advancement of Sciences and Dasman Diabetes Institute, Kuwait RACB-2021-007
Corresponding Author Ashraf Al Madhoun, PhD, Academic Research, Senior Scientist, Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Jassim AlBahar Street, Dasman 15400, Kuwait. ashraf.madhoun@dasmainstitute.org
Key Words Diabetic kidney disease; MicroRNA; MicroRNA-630; Toll-like receptor 4; Inflammation
Core Tip Wu et al identified microRNA-630 as a promising candidate for the management of diabetic kidney disease, exerting its protective effects through the regulation of toll-like receptor 4-mediated inflammatory pathways. Further research elucidating the precise molecular mechanisms underlying microRNA-630’s actions and its therapeutic potential is warranted, with the ultimate goal of developing targeted interventions to alleviate the burden of diabetic kidney disease and improve patient outcomes.
Publish Date 2024-08-27 15:11
Citation

Al Madhoun A. MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease. World J Diabetes 2024; 15(9): 1837-1841

URL https://www.wjgnet.com/1948-9358/full/v15/i9/1837.htm
DOI https://dx.doi.org/10.4239/wjd.v15.i9.1837
Full Article (PDF) WJD-15-1837-with-cover.pdf
Full Article (Word) WJD-15-1837.docx